Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients (Q46587153)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 November 2005
edit
Language Label Description Also known as
English
Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients
scientific article published on 5 November 2005

    Statements

    Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit